Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
10.5 mg budesonide effervescent tablet for orodispersible use[1] Budesonide[1] D00246 (Name: Budesonide)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 98
21 mg budesonide effervescent tablet for orodispersible use[1] Budesonide[1] D00246 (Name: Budesonide)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 98
31mg budesonide effervescent tablet for orodispersible use[1] Budesonide[1] D00246 (Name: Budesonide)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 98
42mg budesonide effervescent tablet for orodispersible use[1] Budesonide[1] D00246 (Name: Budesonide)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 98
5BUDESONIDE[1] Budesonide[1] D00246 (Name: Budesonide)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[9] 66, 93, 94, 95, 96, 97, 98, 228, 299
6Budesonide ( Zentacort Capsules 3mg )[1] Budesonide[1] D00246 (Name: Budesonide)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 96
7Budesonide (6 mg)[1] Budesonide[1] D00246 (Name: Budesonide)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 97
8Budesonide (9 mg)[1] Budesonide[1] D00246 (Name: Budesonide)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 97
9Budesonide 0.5 mg compresse orodispersibili[1] Budesonide[1] D00246 (Name: Budesonide)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 98
10Budesonide 0.5 mg orodispersible tablets[1] Budesonide[1] D00246 (Name: Budesonide)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 98
11Budesonide 0.5mg orodispersible tablet twice daily[1] Budesonide[1] D00246 (Name: Budesonide)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 98
12Budesonide 1 mg compresse orodispersibili[1] Budesonide[1] D00246 (Name: Budesonide)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 98
13Budesonide 1 mg orodispersible tablets[1] Budesonide[1] D00246 (Name: Budesonide)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 98
14Budesonide 1 mg orodispersible tablets (BUL 1 mg)[1] Budesonide[1] D00246 (Name: Budesonide)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 98
15Budesonide 1mg orodispersible tablet twice daily[1] Budesonide[1] D00246 (Name: Budesonide)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 98
16Budesonide 2 mg orodispersible tablets (BUL 2 mg)[1] Budesonide[1] D00246 (Name: Budesonide)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 98
17Budesonide 6 mg prolonged-release capsule, hard (BUX-PVII prototype)[1] Budesonide[1] D00246 (Name: Budesonide)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 97
18Budesonide 6 mg prolonged-release capsules, hard (BUX-PVII prototype)[1] Budesonide[1] D00246 (Name: Budesonide)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 97
19Budesonide 9 mg capsules, hard (BUX-PV)[1] Budesonide[1] D00246 (Name: Budesonide)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 97
20Budesonide 9 mg prolonged-release capsule, hard (BUX-PVII prototype)[1] Budesonide[1] D00246 (Name: Budesonide)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 97
21Budesonide 9 mg prolonged-release capsules, hard (BUX-PVII prototype)[1] Budesonide[1] D00246 (Name: Budesonide)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 97
22Budesonide [0.4mg/ml] viscous suspension[1] Budesonide[1] D00246 (Name: Budesonide)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 98
23Budesonide MMX[1] Budesonide[1] D00246 (Name: Budesonide)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 97
24Budesonide MMX 6 mg Tablet[1] Budesonide[1] D00246 (Name: Budesonide)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 97
25Budesonide MMX®[1] Budesonide[1] D00246 (Name: Budesonide)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 97
26Budesonide MMX® 6 mg[1] Budesonide[1] D00246 (Name: Budesonide)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 97
27Budesonide MMX® 9 mg[1] Budesonide[1] D00246 (Name: Budesonide)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 97
28Budesonide oral suspension[1] Budesonide[1] D00246 (Name: Budesonide)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 98
29Budesonide oral suspension [0.2 mg/ml][1] Budesonide[1] D00246 (Name: Budesonide)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 98
30Budesonide plus Prevacid[1] Budesonide[1] D00246 (Name: Budesonide)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 98
31Budesonide-formoterol single inhaler[2] Budesonide,
Formoterol (Synonym: Budesonide/formoterol Teva)		[4] D00246 (Name: Budesonide),
D01373 ,
D05277 ,
D07990 		[2] ADRB2,
NR3C1 💬		[9] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 299
32Budesonide-MMX[1] Budesonide[1] D00246 (Name: Budesonide)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 97
33Budesonide-MMX®[1] Budesonide[1] D00246 (Name: Budesonide)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 97
34Budesonide-MMX® 6 mg[1] Budesonide[1] D00246 (Name: Budesonide)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 97
35Budesonide-MMX® 9 mg[1] Budesonide[1] D00246 (Name: Budesonide)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 97
36Budesonide-MMX™[1] Budesonide[1] D00246 (Name: Budesonide)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 97
37Budesonide/formoterol[2] Budesonide,
Formoterol (Synonym: Budesonide/formoterol Teva)		[4] D00246 (Name: Budesonide),
D01373 ,
D05277 ,
D07990 		[2] ADRB2,
NR3C1 💬		[9] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 228
38Combination Oral Budesonide and Rectal Hydrocortisone[2] Budesonide,
Hydrocortisone		[2] D00088 ,
D00246 (Name: Budesonide)		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 97
39Compressa effervescente 0,5 mg di budesonide per uso orodispersibile[1] Budesonide[1] D00246 (Name: Budesonide)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 98
40Compressa effervescente 1 mg di budesonide per uso orodispersibile[1] Budesonide[1] D00246 (Name: Budesonide)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 98
41Formoterol/Budesonide[2] Budesonide,
Formoterol (Synonym: Budesonide/formoterol Teva)		[4] D00246 (Name: Budesonide),
D01373 ,
D05277 ,
D07990 		[2] ADRB2,
NR3C1 💬		[9] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 228
42High Dose Budesonide[1] Budesonide[1] D00246 (Name: Budesonide)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 97
43High dose budesonide suspension[1] Budesonide[1] D00246 (Name: Budesonide)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 98
44High dose budesonide tablet[1] Budesonide[1] D00246 (Name: Budesonide)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 98
45High dose of budesonide[1] Budesonide[1] D00246 (Name: Budesonide)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 299
46Inhaled/swallowed budesonide[1] Budesonide[1] D00246 (Name: Budesonide)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 98
47Low Dose Budesonide[1] Budesonide[1] D00246 (Name: Budesonide)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 97
48Low dose budesonide tablet[1] Budesonide[1] D00246 (Name: Budesonide)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 98
49Methylprednisolone or budesonide[2] Budesonide,
Methylprednisolone		[7] D00246 (Name: Budesonide),
D00407 ,
D00751 ,
D00979 ,
D05000 ,
D05001 ,
D05002 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 96
50Oral Budesonide[1] Budesonide[1] D00246 (Name: Budesonide)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 98
51Oral Budesonide Suspension (MB-9)[1] Budesonide[1] D00246 (Name: Budesonide)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 98
52Oral Budesonide Suspension (OBS)[1] Budesonide[1] D00246 (Name: Budesonide)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 98
53Oral Viscous Budesonide[1] Budesonide[1] D00246 (Name: Budesonide)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 98
54Oral Viscous Budesonide (OVB)[1] Budesonide[1] D00246 (Name: Budesonide)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 98
55Viscous/swallowed budesonide[1] Budesonide[1] D00246 (Name: Budesonide)[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 98